Literature DB >> 25241334

Variable phenotypes of multiple synostosis syndrome in patients with novel NOG mutations.

Beom Hee Lee1, Ok-Hwa Kim2, Hye-Kyung Yoon3, Jae-Min Kim1, Kunbo Park4, Han-Wook Yoo5.   

Abstract

Multiple synostosis syndrome (SYNS) is an autosomal dominant skeletal disorder characterized by facial dysmorphism, progressive fusion of multiple joints, and conductive hearing loss. Currently, three genes, NOG, GDF5, and FGF9, have been identified as causative of SYNS. However, due to the phenotypic and genotypic heterogeneity of SYNS, as well as its extreme rarity, it is difficult to diagnose, either by clinical or genetic means. Here, we describe three unrelated Korean families with three different, novel NOG mutations. These mutations are located on the region of the protein critical for appropriate NOG function. The patients shared the general features of SYNS, but the phenotype was expressed differently both within and between the families. In addition, this phenotypic diversity was irrespective of the age of patients, indicating the importance of surveillance for the full spectrum of SYNS in each affected patient. Our report expands understanding of this rare condition from both clinical and genetic perspectives.
Copyright © 2014 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Multiple synostosis syndrome; NOG; Symphalangism

Mesh:

Substances:

Year:  2014        PMID: 25241334     DOI: 10.1016/j.jbspin.2014.07.006

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

1.  Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Polyzois Makras; Martina Rauner; Linda Sonnleitner; Gerhard Hawa; Elena Tsourdi; Maria P Yavropoulou; Albert Missbichler; Evangelos Terpos
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-09-01       Impact factor: 2.041

2.  Identification of a novel mutation of NOG in family with proximal symphalangism and early genetic counseling.

Authors:  Cong Ma; Lv Liu; Fang-Na Wang; Hai-Shen Tian; Yan Luo; Rong Yu; Liang-Liang Fan; Ya-Li Li
Journal:  BMC Med Genet       Date:  2019-11-06       Impact factor: 2.103

3.  Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus.

Authors:  Wei-Lin Zhang; Duo-Yi Zhao; Wei Zhao; Yan Cui; Qin Li; Zhi-Yu Zhang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

4.  Novel NOG (p.P42S) mutation causes proximal symphalangism in a four-generation Chinese family.

Authors:  Yanwei Sha; Ding Ma; Ning Zhang; Xiaoli Wei; Wensheng Liu; Xiong Wang
Journal:  BMC Med Genet       Date:  2019-08-01       Impact factor: 2.103

5.  Clinical observation and genetic analysis of a SYNS1 family caused by novel NOG gene mutation.

Authors:  Zhao Zhang; Yu Lu; Jing-Yuan Cao; Li Wang; Lin-Ke Li; Chao Wang; Xuan Ye; Yi-Ming Ji; Lin-Yi Tu; Yi Sun
Journal:  Mol Genet Genomic Med       Date:  2022-03-25       Impact factor: 2.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.